Sun Pharmaceutical launches novel ophthalmology treatment CEQUA in India

25 Apr 2023 Evaluate

Sun Pharmaceutical Industries has launched a novel ophthalmology treatment, CEQUA, in India for patients who have Dry Eye Disease (DED) with inflammation, a commonly occurring condition. CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology.

Global clinical trials have shown that CEQUA provides faster results and is comfortable to most of the patients right from the start of treatment. CEQUA is backed by years of clinical experience in the U.S. and other geographies. It is a welcome addition to our treatment toolkit.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×